May 16, 2013 - vival from date of first TACE treatment to date of death. Patients who were still alive ...... Major complication rate was 4.3%; one patient with prior history of Whipple's ...... Reidy-Lagunes, Diane - Paper 35. Rezai, Pedram ...
Purpose: To evaluate TIPS outcomes, complications, and procedural variables ... Results: No differences in demographic characteristics were found between the ...
May 5, 2016 - Percutaneous Image-Guided Cryoablation of Soft-Tissue Venous ... sue and treated with cryoablation for symptomatic recurrences after ...
nous Incompetence in Patients with R-to-L Shunt: In- ... assessed by blinded central reviewers. ... shunt-positive patients treated with polidocanol MF, 90%.
unfortunately do not routinely use personal dosimeters even when made ... Recently, studies have explored the use of electronic active dosimeters that provide.
Results: In 1494 pts (96.9%) VAS and ODQ significantly changed from 8.21.8 to 1.11.6 (p.0005 Wicoxon test) and from 68.77.6% to 18.58.2% (p.0005 t-test) re-.
consists of a self-expanding stent and expanded PTFE. It has been used in an off-label manner to treat hemodialysis access. Data was retrospectively reviewed ...
of blunt splenic trauma has become the treatment of choice for hemodynamically stable patients. Therefore, the radiologist/interventional radiologist is playing a.
Mercy Hospital. Chicago, Illinois. Antonio Bozzani, MD. I.R.C.C.S. Policlinico San Matteo. Pavia, Italy. Jeremy D. Colli
angiography revealed that extravasation ceased after the procedure (Fig 4). Follow-up computed tomography performed 16 days after the procedure revealed ...
Interventional radiology (IR) has traditionally been .... 548 ⢠Antibiotic Prophylaxis for the Interventional Radiologist ...... tive antibiotic therapy in orthopedic.
Catheter performance was investigated at high hemodialysis flow rate (400 mL/min). Blood was assumed .... 1,060 kg/m3). Catheter ... motion in discrete form by using a finite volume-based ..... novel formulation for blood trauma prediction by a modif
characteristics and advanced age at the time of treatment yet maintained durable ... (mRECIST), time to secondary therapy, and overall survival. Results: Post ...
outline for treatment of any future occurrences of this ... dominal desmoid tumors and a colectomy was treated with .... Endovenous Laser Treatment and Stab.
Clayton E, Malik S, Bonnel A, Mu Y, Olthoff K, Shaked A, Abt P,. Peterman H, Reddy K, ... HPFS and OS were not significantly affected by the choice of Yttrium-90.
lumbar vertebral body(ies). To date, no study has evaluated long- term clinical outcomes among patients with painful bone metastases or bone lesions after ...
pulmonary artery. No other ... on reduction in follow-up pulmonary artery pressure and resolution ... thrombectomy (MT), and pharmacomechanical thrombolysis.
Raynham, Massachusetts) was advanced coaxially over a. 0.014-inch, 300-cm guide wire (Transend; Stryker Neuro- vascular, Fremont, California) through the ...
tery, experience of the radiologist and location of the cath- eter's tip. Abstract No. ... 7 had a arterial pseudoaneurysm, 7 had a port pocket he- matoma and 3 had ...
High-Frequency Electroporation for Cancer Therapy (US Application. 13/332,133 with ..... simulations of liver ablation by irreversible electroporation: impact of.
Randy O. Chang, BS, Devin Vaswani, MD, Robert E. Stone, MD,. Ari N. Berlin ... Thomas P. Madaelil, MD, Ramy A. Shoela, MD, Travis J. Hillen, MD,. Jeremiah ...
St. Paul, Minnesota) and loop snare was performed. An- gioplasty was .... One patient (< 1%) had a Simon nitinol IVC filter (Bard Peripheral Vascular) with.
PURPOSE: Cholesterol microembolization may explain some treatment failures after renal artery stent placement. The identification of cholesterol crystals may ...
May 11, 2014 - Methods: We divided 45 patients into cryo-immunotherapy (21 ... apy was associated with a better prognosis than single cryo-immunotherapy.
ABSTRACTS FROM WCIO
World Conference on Interventional Oncology (WCIO) 2014 May 11-14, 2014, New York, New York
S. Hunt, T. Bitterman, M. Hoteit, G. Nadolski Objectives: Unresectable very small HCC (vsHCC,
